Panelists in this video:
+ Dr Ranjit Barshikar, CEO – QbD International; United Nations Adviser – Geneva
+ Dr Rajiv Desai, Executive VP – Corporate Quality, Lupin
+ Dr Sanjay Kumar Jain, President – India, Amneal Pharmaceuticals
+ Dr BM Rao, Head of Quality for Emerging Markets, ASAT & Corporate Quality Control, Dr Reddy’s Laboratories
+ Ranjith Ramakrishnan, Head Quality Control Biologics, Syngene International
Key Highlights:
+ Including digitalisation as a subject in pharma courses is the need of the hour: Dr Ranjit Barshikar, CEO – QbD International; United Nations Adviser – Geneva
+ More automation of documentation will mean less errors. We will be able to get better compliance in our systems with digitalisation. We should be able to integrate the information from various systems and vendors: Dr Rajiv Desai, Executive VP – Corporate Quality, Lupin
+ Technology in labs have increased the level of data integrity, reduced the manual and transcription error and enhanced the flexibility in tracking the sample and inventory management: Dr Sanjay Kumar Jain, President – India, Amneal Pharmaceuticals
+ We need a holistic approach if we want to achieve complete data integrity in labs while dealing with the technology: Dr BM Rao, Head of Quality for Emerging Markets, ASAT & Corporate Quality Control, Dr Reddy’s Laboratories
+ Automation, robotics, digitalisation will reduce errors due to human fatigue and this will add to the quality systems of the organisation: Ranjith Ramakrishnan, Head Quality Control Biologics, Syngene International